Taekyung Chemical KRX:006890KOSPI
태경케미컬 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, Taekyung Chemical reported revenue of ₩12.2bn, down 17.3% year on year, and an operating loss of ₩1.8bn. Taekyung Chemical (태경케미컬) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Swung to loss Screener
Taekyung Chemical quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩12.2bn | -17.3% | −₩1.8bn | ₩343m |
| Q1 2026 | ₩14.0bn | -11.5% | −₩653m | ₩1.7bn |
| Q4 2025 derived | ₩14.5bn | -9.9% | −₩706m | ₩3.2bn |
| Q3 2025 | ₩16.3bn | -20.4% | ₩950m | ₩1.9bn |
| Q2 2025 | ₩14.7bn | -18.1% | ₩767m | ₩1.4bn |
| Q1 2025 | ₩15.8bn | -4.4% | ₩1.1bn | ₩2.2bn |
| Q4 2024 derived | ₩16.1bn | -5.0% | ₩2.1bn | ₩1.3bn |
| Q3 2024 | ₩20.5bn | +5.5% | ₩4.5bn | ₩3.5bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
Taekyung Chemical top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Taekyung Chemical news Korean headlines
No articles yet.